These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1308830)

  • 1. Transfusion-associated graft-versus-host disease in patients with Hodgkin's disease and T cell lymphoma.
    Baglin TP; Joysey VC; Horsford J; Johnson RT; Broadbent V; Marcus RE
    Transfus Med; 1992 Sep; 2(3):195-9. PubMed ID: 1308830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
    Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
    Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing.
    Dinsmore RE; Straus DJ; Pollack MS; Woodruff JM; Garrett TJ; Young CW; Clarkson BD; Dupont B
    Blood; 1980 May; 55(5):831-4. PubMed ID: 7362871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft versus host disease following transfusion of normal blood products to patients with malignancies.
    Kessinger A; Armitage JO; Klassen LW; Landmark JD; Hayes JM; Larsen AE; Purtilo DT
    J Surg Oncol; 1987 Nov; 36(3):206-9. PubMed ID: 3316850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion].
    Nakamoto T; Nishi S; Shindoh M; Hayashi M; Yukioka H; Fujimori M; Maekawa N
    Masui; 1995 Sep; 44(9):1261-4. PubMed ID: 8523663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute graft-versus-host disease resulting from normal donor blood transfusions.
    Burns LJ; Westberg MW; Burns CP; Klassen LW; Goeken NE; Ray TL; Macfarlane DE
    Acta Haematol; 1984; 71(4):270-6. PubMed ID: 6426240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-transfusion graft versus host disease in a patient with Hodgkin's disease].
    Tomás Martínez JF; Abad Hernández MJ; Cortina de la Calle MP; Canut Blasco A; Nieto González MJ; Corral Alonso M; San Miguel Izquierdo JF; López-Borrasca A
    Med Clin (Barc); 1989 Apr; 92(13):503-6. PubMed ID: 2747313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion-associated graft-vs-host disease in a patient with Hodgkin's disease].
    Lillevang ST; Andersen CB; Schmidt KG; Riisom K
    Ugeskr Laeger; 1992 Oct; 154(43):2979-80. PubMed ID: 1462387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.
    Peggs KS; Hunter A; Chopra R; Parker A; Mahendra P; Milligan D; Craddock C; Pettengell R; Dogan A; Thomson KJ; Morris EC; Hale G; Waldmann H; Goldstone AH; Linch DC; Mackinnon S
    Lancet; 2005 Jun 4-10; 365(9475):1934-41. PubMed ID: 15936420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-associated graft-versus-host disease and its prevention.
    Williamson LM; Warwick RM
    Blood Rev; 1995 Dec; 9(4):251-61. PubMed ID: 8839400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion associated graft-versus-host disease after cardiac surgery: response to antithymocyte-globulin and corticosteroid therapy.
    Prince M; Szer J; van der Weyden MB; Pedersen JS; Holdsworth RF; Whyte G
    Aust N Z J Med; 1991 Feb; 21(1):43-6. PubMed ID: 2036076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of transfusion-associated graft-versus-host disease.
    Yasukawa M; Shinozaki F; Hato T; Takada K; Ishii Y; Tamai T; Takamatsu H; Shiobara S; Yoshizaki K; Fujita S
    Br J Haematol; 1994 Apr; 86(4):831-6. PubMed ID: 7918080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor.
    Ryo R; Saigo K; Hashimoto M; Kohsaki M; Yasufuku M; Watanabe N; Okada M; Tadokoro K; Juji T
    Vox Sang; 1999; 76(4):241-6. PubMed ID: 10394145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
    Labotka RJ; Radvany R
    Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-T cell (T12) antibody treatment of graft-versus-host disease in severe combined immunodeficiency: targeting of antibody and activation of complement on CD8+ cytotoxic T cell surfaces.
    Blomquist MD; Boggards M; Hanson IC; Rosenblatt HM; Pollack MS; Hawkins E; Ritz J; Shearer WT
    J Allergy Clin Immunol; 1991 May; 87(5):1029-33. PubMed ID: 1902852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.
    Hutchinson K; Kopko PM; Muto KN; Tuscano J; O'Donnell RT; Holland PV; Richman C; Paglieroni TG; Wun T
    Transfusion; 2002 Dec; 42(12):1567-72. PubMed ID: 12473136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
    Leitman SF; Tisdale JF; Bolan CD; Popovsky MA; Klippel JH; Balow JE; Boumpas DT; Illei GG
    Transfusion; 2003 Dec; 43(12):1667-71. PubMed ID: 14641861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.